Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Live Attenuated Varicella Vaccine in Healthy Children and Adults
ChiCTR2200066991Phase 3Not yet recruiting
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chickenpox comparing Varicella vaccine with Placebo (2 arms). Primary endpoints: Protective efficacy against laboratory-confirmed varicella, Neutralizing antibody response and 3 more. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on ChiCTR2200066991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066991.